Current Edition


Regeneron warns its antibody drug may be less potent versus omicron

Regeneron’s drug is the top-selling COVID-19 treatment in the U.S., one of three antibody drugs currently authorized by the Food and Drug Administration for people …

Continue Reading →

Bio-Rad Launches IgA and IgM SARS-CoV-2 Bio-Plex Pro Immunoassay Panels to Study COVID-19 Antibody Response

The Panels Complete Bio-Rad’s Set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for Detection of Antibodies Against Four SARS-CoV-2 Antigens HERCULES, Calif.–September 30, 2021–Bio-Rad …

Continue Reading →